EP3843721A4 - Ophthalmische zusammensetzungen und verfahren zur verwendung - Google Patents

Ophthalmische zusammensetzungen und verfahren zur verwendung Download PDF

Info

Publication number
EP3843721A4
EP3843721A4 EP19856338.9A EP19856338A EP3843721A4 EP 3843721 A4 EP3843721 A4 EP 3843721A4 EP 19856338 A EP19856338 A EP 19856338A EP 3843721 A4 EP3843721 A4 EP 3843721A4
Authority
EP
European Patent Office
Prior art keywords
methods
ophthalmic compositions
ophthalmic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19856338.9A
Other languages
English (en)
French (fr)
Other versions
EP3843721A1 (de
Inventor
Rasappa Arumugham
Arun UPADHYAY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ocugen Inc
Original Assignee
Ocugen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/116,872 external-priority patent/US20190008920A1/en
Application filed by Ocugen Inc filed Critical Ocugen Inc
Publication of EP3843721A1 publication Critical patent/EP3843721A1/de
Publication of EP3843721A4 publication Critical patent/EP3843721A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19856338.9A 2018-08-29 2019-08-29 Ophthalmische zusammensetzungen und verfahren zur verwendung Withdrawn EP3843721A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/116,872 US20190008920A1 (en) 2017-05-19 2018-08-29 Ophthalmic compositions and methods of use
PCT/US2019/048721 WO2020047197A1 (en) 2018-08-29 2019-08-29 Ophthalmic compositions and methods of use

Publications (2)

Publication Number Publication Date
EP3843721A1 EP3843721A1 (de) 2021-07-07
EP3843721A4 true EP3843721A4 (de) 2022-10-12

Family

ID=69644699

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19856338.9A Withdrawn EP3843721A4 (de) 2018-08-29 2019-08-29 Ophthalmische zusammensetzungen und verfahren zur verwendung

Country Status (4)

Country Link
EP (1) EP3843721A4 (de)
CN (1) CN111212642A (de)
CA (1) CA3115664A1 (de)
WO (1) WO2020047197A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024042550A1 (en) * 2022-08-25 2024-02-29 Sentiss Pharma Private Limited Ophthalmic combination composition

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070225217A1 (en) * 2005-11-09 2007-09-27 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
EP1827373B1 (de) * 2004-11-09 2008-12-03 Novagali Pharma SA Prostaglandine enthaltende ophthalmische emulsionen
AU2012351948A1 (en) * 2011-12-16 2014-07-10 Allergan, Inc. Ophthalmic compositions comprising polyvinyl capralactam - polyvinyl acetate - polyethylene glycol graft copolymer
US9034830B2 (en) * 2009-10-30 2015-05-19 Intratus, Inc. Methods and compositions for sustained delivery of drugs
US9597328B2 (en) * 2015-02-24 2017-03-21 Ocugen, Inc. Methods and compositions for treating dry eye disease and other eye disorders
US20170304316A1 (en) * 2014-10-20 2017-10-26 Sentiss Pharma Private Limited Ophthalmic Solution
US20180055943A1 (en) * 2016-08-23 2018-03-01 Ira Jason Salzman Ophthalmic lubricating spray
US20180153885A1 (en) * 2015-02-24 2018-06-07 The Board Of Trustees Of The University Of Illinois Preservative free ocular compositions and methods for using the same for treating dry eye disease and other eye disorders
WO2018139991A1 (en) * 2017-01-24 2018-08-02 Macregen, Inc. Treatment of age-related degeneration and other eye diseases with apolipoprotein mimetics
US20180221278A1 (en) * 2015-02-24 2018-08-09 Ocugen, Inc. Prsustained release opthalmic formuation and methods for using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2094688B1 (es) * 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
WO2001041806A1 (fr) * 1999-12-07 2001-06-14 Rohto Pharmaceutical Co., Ltd. Compositions ophtalmiques
MX2007010025A (es) * 2007-08-17 2009-02-25 Arturo Jimenez Bayardo Composición farmacéutica para tratamiento de hipertensión ocular.
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
CN102895245A (zh) * 2012-10-30 2013-01-30 河南牧翔动物药业有限公司 一种复方甲氧苄啶与盐酸多西环素纳米乳制剂及其制备方法
US20170239331A1 (en) * 2014-10-15 2017-08-24 Rapid Pathogen Screening, Inc. Formulations for histatin protectives and therapeutics
MX2019003623A (es) * 2016-09-28 2019-09-23 Medicon Pharmaceuticals Inc Composiciones y metodos para el tratamiento de afecciones oftalmicas.

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1827373B1 (de) * 2004-11-09 2008-12-03 Novagali Pharma SA Prostaglandine enthaltende ophthalmische emulsionen
US20070225217A1 (en) * 2005-11-09 2007-09-27 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
US9034830B2 (en) * 2009-10-30 2015-05-19 Intratus, Inc. Methods and compositions for sustained delivery of drugs
AU2012351948A1 (en) * 2011-12-16 2014-07-10 Allergan, Inc. Ophthalmic compositions comprising polyvinyl capralactam - polyvinyl acetate - polyethylene glycol graft copolymer
US20170304316A1 (en) * 2014-10-20 2017-10-26 Sentiss Pharma Private Limited Ophthalmic Solution
US9597328B2 (en) * 2015-02-24 2017-03-21 Ocugen, Inc. Methods and compositions for treating dry eye disease and other eye disorders
US20180153885A1 (en) * 2015-02-24 2018-06-07 The Board Of Trustees Of The University Of Illinois Preservative free ocular compositions and methods for using the same for treating dry eye disease and other eye disorders
US20180221278A1 (en) * 2015-02-24 2018-08-09 Ocugen, Inc. Prsustained release opthalmic formuation and methods for using the same
US20180055943A1 (en) * 2016-08-23 2018-03-01 Ira Jason Salzman Ophthalmic lubricating spray
WO2018139991A1 (en) * 2017-01-24 2018-08-02 Macregen, Inc. Treatment of age-related degeneration and other eye diseases with apolipoprotein mimetics

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2020047197A1 *

Also Published As

Publication number Publication date
CA3115664A1 (en) 2020-03-05
EP3843721A1 (de) 2021-07-07
CN111212642A (zh) 2020-05-29
WO2020047197A1 (en) 2020-03-05

Similar Documents

Publication Publication Date Title
EP3704239A4 (de) Casz-zusammensetzungen und verfahren zur verwendung
EP3775203A4 (de) Oligonukleotidzusammensetzungen und verfahren zur verwendung davon
EP3624773A4 (de) Ophthalmische zusammensetzungen und verfahren zur verwendung
EP3790596A4 (de) Oligonucleotidzusammensetzungen und verfahren zu ihrer verwendung
EP3576782A4 (de) Konstrukt-peptid-zusammensetzungen und verfahren zur verwendung davon
EP3704254A4 (de) Cas12c-zusammensetzungen und verfahren zur verwendung
EP3595653A4 (de) Zusammensetzungen von plinabulin und verwendung davon
EP3265096A4 (de) Ophthalmische zusammensetzungen und verfahren zur verwendung davon
EP3691677A4 (de) Saccharid-polypeptidkonjugat-zusammensetzungen und verfahren zur verwendung davon
EP3829307A4 (de) Wismuth-thiolzusammensetzungen und verwendungsverfahren
EP3802553A4 (de) Siliziumhaltige zusammensetzungen und ihre verwendung
EP3600372A4 (de) Synthekinzusammensetzungen und verfahren zur verwendung
EP3893917A4 (de) Il-15-zusammensetzungen und verfahren zur verwendung davon
EP3886853A4 (de) Diarylhydantoiverbindungen und verfahren zur verwendung davon
EP3740576A4 (de) Therapeutische zusammensetzungen und verfahren zur herstellung und verwendung davon
EP3856214A4 (de) Mikrobielle zusammensetzungen und verfahren zur verwendung
EP3863630A4 (de) Zusammensetzungen und verfahren zur behandlung von presbyopie
EP3601460A4 (de) Polierzusammensetzungen und verfahren zu ihrer verwendung
EP3833340A4 (de) Zusammensetzungen und verfahren zur behandlung von presbyopie
EP3768315A4 (de) Fc-varianten-zusammensetzungen und verfahren zur verwendung davon
EP3826652A4 (de) Leber-gallen-pankreas-gewebe und verfahren zu seiner herstellung
EP4034605A4 (de) Polierzusammensetzungen und verfahren zu ihrer verwendung
EP3713553A4 (de) Zusammensetzungen und verfahren zur behandlung von augenkrankheiten
EP4045226A4 (de) Polierzusammensetzungen und verfahren zu ihrer verwendung
AU2018292381A1 (en) Cosmetic compositions and methods of use

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20210329

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 27/02 20060101ALI20220602BHEP

Ipc: A61K 9/107 20060101ALI20220602BHEP

Ipc: A61K 31/436 20060101ALI20220602BHEP

Ipc: A61K 31/56 20060101ALI20220602BHEP

Ipc: A61K 31/4725 20060101ALI20220602BHEP

Ipc: A61K 38/13 20060101ALI20220602BHEP

Ipc: A61K 31/498 20060101ALI20220602BHEP

Ipc: A61K 31/137 20060101ALI20220602BHEP

Ipc: A61K 47/32 20060101ALI20220602BHEP

Ipc: A61K 47/18 20170101ALI20220602BHEP

Ipc: A61K 47/12 20060101ALI20220602BHEP

Ipc: A61K 47/10 20170101ALI20220602BHEP

Ipc: A61K 47/26 20060101ALI20220602BHEP

Ipc: A61K 47/44 20170101ALI20220602BHEP

Ipc: A61K 31/573 20060101ALI20220602BHEP

Ipc: A61K 31/407 20060101ALI20220602BHEP

Ipc: A61K 9/08 20060101ALI20220602BHEP

Ipc: A61K 9/00 20060101ALI20220602BHEP

Ipc: A61K 31/417 20060101AFI20220602BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20220913

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 27/02 20060101ALI20220907BHEP

Ipc: A61K 9/107 20060101ALI20220907BHEP

Ipc: A61K 31/436 20060101ALI20220907BHEP

Ipc: A61K 31/56 20060101ALI20220907BHEP

Ipc: A61K 31/4725 20060101ALI20220907BHEP

Ipc: A61K 38/13 20060101ALI20220907BHEP

Ipc: A61K 31/498 20060101ALI20220907BHEP

Ipc: A61K 31/137 20060101ALI20220907BHEP

Ipc: A61K 47/32 20060101ALI20220907BHEP

Ipc: A61K 47/18 20170101ALI20220907BHEP

Ipc: A61K 47/12 20060101ALI20220907BHEP

Ipc: A61K 47/10 20170101ALI20220907BHEP

Ipc: A61K 47/26 20060101ALI20220907BHEP

Ipc: A61K 47/44 20170101ALI20220907BHEP

Ipc: A61K 31/573 20060101ALI20220907BHEP

Ipc: A61K 31/407 20060101ALI20220907BHEP

Ipc: A61K 9/08 20060101ALI20220907BHEP

Ipc: A61K 9/00 20060101ALI20220907BHEP

Ipc: A61K 31/417 20060101AFI20220907BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230412